Dimethyl fumarate mitigates optic neuritis

PURPOSE: Dimethyl fumarate (DMF) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing-remitting multiple sclerosis (RRMS), a demyelinating autoimmune disease characterized by acute episodes of motor, sensory, and cognitive symptoms. Optic neuritis is an epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zyla, Katarzyna, Larabee, Chelsea M., Georgescu, Constantin, Berkley, Chelsea, Reyna, Tania, Plafker, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707756/
https://www.ncbi.nlm.nih.gov/pubmed/31523122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707756/
https://www.ncbi.nlm.nih.gov/pubmed/31523122

Ejemplares similares